These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28228232)

  • 1. Hormone receptor expression profile of low-grade serous ovarian cancers.
    Buttarelli M; Mascilini F; Zannoni GF; Ciucci A; Martinelli E; Filippetti F; Scambia G; Ferrandina G; Gallo D
    Gynecol Oncol; 2017 May; 145(2):352-360. PubMed ID: 28228232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.
    Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D
    Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer.
    De Stefano I; Zannoni GF; Prisco MG; Fagotti A; Tortorella L; Vizzielli G; Mencaglia L; Scambia G; Gallo D
    Gynecol Oncol; 2011 Sep; 122(3):573-9. PubMed ID: 21665249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
    Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
    BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
    Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V
    Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.
    Sehouli J; Braicu EI; Richter R; Denkert C; Jank P; Jurmeister PS; Kunze CA; Budczies J; Darb-Esfahani S; Schmitt WD; Traut A; Grabowski J; Taube ET; Plett H
    Hum Pathol; 2019 Mar; 85():299-308. PubMed ID: 30428389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma.
    Llaurado Fernandez M; Dawson A; Kim H; Lam N; Russell H; Bruce M; Bittner M; Hoenisch J; Scott SA; Talhouk A; Chiu D; Provencher D; Nourmoussavi M; DiMattia G; Lee CH; Gilks CB; Köbel M; Carey MS
    Gynecol Oncol; 2020 Apr; 157(1):12-20. PubMed ID: 31954537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell Lines.
    Shanta K; Nakayama K; Hossain MM; Razia S; Ishibashi T; Ishikawa M; Yamashita H; Kanno K; Sato S; Nakayama S; Otsuki Y; Kyo S
    Curr Oncol; 2022 Jun; 29(6):4020-4033. PubMed ID: 35735430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas.
    Aghmesheh M; Edwards L; Clarke CL; Byth K; Katzenellenbogen BS; Russell PJ; Friedlander M; Tucker KM; de Fazio A
    Gynecol Oncol; 2005 Apr; 97(1):16-25. PubMed ID: 15790432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor β: Potential target for therapy in adult granulosa cell tumors?
    Ciucci A; Ferrandina G; Mascilini F; Filippetti F; Scambia G; Zannoni GF; Gallo D
    Gynecol Oncol; 2018 Jul; 150(1):158-165. PubMed ID: 29786517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low androgen/progesterone or high oestrogen/androgen receptors ratio in serous ovarian cancer predicts longer survival.
    Gogola-Mruk J; Pietrus M; Piechowicz M; Milian-Ciesielska K; Głód P; Wolnicka-Glubisz A; Szpor J; Ptak A
    Reprod Biol; 2024 Sep; 24(3):100917. PubMed ID: 38970978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
    Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT
    BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of ERα, ERβ, and TFF1 in type I and II ovarian tumors.
    Abdou AG; Aiad HA; Asaad NY; Abd El-Wahed MM; Serag El-Dien M
    Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):421-32. PubMed ID: 24162262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor beta1 and the beta2/betacx isoforms in nonneoplastic endometrium and in endometrioid carcinoma.
    Chakravarty D; Srinivasan R; Ghosh S; Gopalan S; Rajwanshi A; Majumdar S
    Int J Gynecol Cancer; 2007; 17(4):905-13. PubMed ID: 17309672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival.
    Kamal AM; Bulmer JN; DeCruze SB; Stringfellow HF; Martin-Hirsch P; Hapangama DK
    Br J Cancer; 2016 Mar; 114(6):688-96. PubMed ID: 26930451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells.
    Lau KM; Mok SC; Ho SM
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5722-7. PubMed ID: 10318951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor alpha and beta expression in a case matched series of serous and endometrioid adenocarcinomas of the ovary.
    Geisler JP; Buller E; Manahan KJ
    Eur J Gynaecol Oncol; 2008; 29(2):126-8. PubMed ID: 18459544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors.
    Chu S; Mamers P; Burger HG; Fuller PJ
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1200-5. PubMed ID: 10720062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M; Lynch IJ; Bhardwaj B
    Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
    Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
    Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.